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Abstract
Identifying molecular targets that are able to buffer the consequences of stress and therefore restore brain homeostasis is 
essential to develop treatments for stress-related disorders. Down-regulated in renal cell carcinoma 1 (DRR1) is a unique 
stress-induced protein in the brain and has been recently proposed to modulate stress resilience. Interestingly, DRR1 shows 
a prominent expression in the limbic system of the adult mouse. Here, we analyzed the neuroanatomical and cellular expres-
sion patterns of DRR1 in the adult mouse brain using in situ hybridization, immunofluorescence and Western blot. Abundant 
expression of DRR1 mRNA and protein was confirmed in the adult mouse brain with pronounced differences between distinct 
brain regions. The strongest DRR1 signal was detected in the neocortex, the CA3 region of the hippocampus, the lateral 
septum and the cerebellum. DRR1 was also present in circumventricular organs and its connecting regions. Additionally, 
DRR1 was present in non-neuronal tissues like the choroid plexus and ependyma. Within cells, DRR1 protein was distributed 
in a punctate pattern in several subcellular compartments including cytosol, nucleus as well as some pre- and postsynaptic 
specializations. Glucocorticoid receptor activation (dexamethasone 10 mg/kg s.c.) induced DRR1 expression throughout 
the brain, with particularly strong induction in white matter and fiber tracts and in membrane-rich structures. This specific 
expression pattern and stress modulation of DRR1 point to a role of DRR1 in regulating how cells sense and integrate signals 
from the environment and thus in restoring brain homeostasis after stressful challenges.
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Introduction
Stress induces a plethora of molecular changes in the brain 
aimed at facilitating individual adaptation to new environmen-
tal demands. However, in individuals at risk, stress can trig-
ger deleterious consequences on neuronal function through 
mechanisms that are not fully understood (de Kloet et al. 2005; 
Popoli et al. 2012; Sousa and Almeida 2012; Duman et al. 
2016). Glucocorticoid receptor (GR) activation induces gene 
transcription and mediates some—but not all—of the long-
term effects of stress. GR-mediated mechanisms are prominent 
in late phase response to stress (slow stress-induced changes) 
and appear to be involved in homeostasis restoration and con-
solidation of relevant information for future use (de Kloet et al. 
2005; Yau and Seckl 2012). Thus, the characterization of GR Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s0042 9-018-1737-7) contains 
supplementary material, which is available to authorized users.
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targets responsible for restoring homeostasis and attenuating 
the negative consequences of stress is a promising route for the 
development of treatments for stress-related disorders.
The stress-inducible gene down-regulated in renal cell car-
cinoma 1 (DRR1, also known as TU3A and Fam107A) was 
initially identified as a putative tumor suppressor gene in renal 
cell carcinoma (Yamato et al. 2000; Wang et al. 2000), then 
as unique gene increased in both psychiatric and neurodegen-
erative disorders (Shao and Vawter 2008; Li et al. 2014; Shin 
et al. 2016) and recently pointed as a novel molecular player 
promoting stress resilience (Masana et al. 2014, 2015; van 
der Kooij et al. 2016), supporting the involvement of DRR1 
in modulating neuronal function under pathophysiological 
conditions. Interestingly, DRR1 is an actin-interacting pro-
tein and during recent years, neuronal actin dysfunction has 
been suggested as a potential shared pathological mechanism 
in neurodevelopmental disorders (van der Kooij et al. 2016; 
Yan et al. 2016).
GR activation increases DRR1 gene expression in stress-
relevant brain regions such as the hypothalamic paraventricular 
nucleus and the hippocampal CA3 region (Liebl et al. 2009; 
Schmidt et al. 2011), lateral septum (Masana et al. 2014) and 
prefrontal cortex (Stankiewicz et al. 2014). Virus-induced 
overexpression of DRR1 in these brain regions improves cog-
nitive performance (Schmidt et al. 2011) and increases social 
behavior (Masana et al. 2014), suggesting that DRR1 facilitate 
specific behaviors which might be protective against some of 
the deleterious consequences of stress exposure.
Interestingly, DRR1 protein is strongly conserved among 
species (Zhao et al. 2007; Schmidt et al. 2011) and par-
ticularly involved in the development of the nervous system 
(Pankratz et al. 2007; Zhao et al. 2007; Asano et al. 2010; 
Pollen et al. 2015). During mouse embryonic development, 
DRR1 is expressed in axonal projections of the central and 
peripheral nervous system (Asano et al. 2010). The neuro-
anatomical DRR1 mRNA distribution examined so far in the 
adult mouse brain reveals a distinct spatial DRR1 expression 
pattern (Schmidt et al. 2011). However, an exhaustive char-
acterization of DRR1 expression in the adult mouse brain 
has not been conducted so far.
In the present study, we aimed to (1) thoroughly charac-
terize DRR1 mRNA and protein expression pattern in the 
adult mouse brain and (2) to identify in which brain regions 
and subcellular localization DRR1 expression is modulated 
by glucocorticoids.
Materials and methods
Animals
Male C57/Bl6N mice (Charles River Laboratories) (> 12 
weeks old) were used for all experiments. Animals were 
single housed and kept on a 12-h light/dark cycle (lights 
on at 7:00 AM), at room temperature of 23 ± 2 °C, with 
food and water provided ad libitum. All efforts were made 
to minimize animal suffering during the experiments. All 
experiments were carried out in the animal facilities of the 
Max Planck Institute of Psychiatry in Munich, Germany.
Dexamethasone treatment
Dexamethasone-21-dihydrogen-phosphate disodium salt 
(DEX)  (Fortecortin®-inject 100 mg (10 ml), Merck Pharma 
GmbH, Germany), a potent synthetic agonist of the gluco-
corticoid receptor, was diluted to a final concentration of 
2 mg/ml with 0.9% saline and injected sub-cutaneously (s.c.) 
with a single dosage of 10 mg/kg body weight between 8 
and 9 am (~ 130 μl). Vehicle-treated animals (Veh, control) 
were injected with the corresponding volume of 0.9% saline. 
All animals were killed 8 h post-injection under isoflurane 
anesthesia, trunk blood samples collected for corticosterone 
levels assessment using a radioimmunoassay kit (MP Bio-
medicals Inc; sensitivity 6.25 ng/ml) as previously described 
(Wagner et al. 2011), and brains processed for in situ hybrid-
ization and Western blot analysis. Three batches of animals 
were used. First batch (n = 6 vehicle; n = 6 DEX): one brain 
hemisphere was used for hippocampal total protein extrac-
tion and analysis, the other for in situ hybridization. Second 
batch (n = 6 Vehicle; n = 6 DEX): both hippocampi were dis-
sected and subjected to subcellular fractionation for protein 
analysis (cytosol, membrane, nuclei, cytoskeleton). Third 
batch: 6 hippocampi pools/group (4 mice hippocampi/pool) 
were used for subcellular fractionation.
In situ hybridization
In situ hybridization was performed as previously reported 
(Schmidt et al. 2011; Masana et al. 2014, 2015). Brains were 
quickly removed, frozen in isopentane and stored at − 20 °C. 
Sections were cut at 18 µm using a cryostat microtome, 
thaw-mounted on Superfrost plus slides (Menzel Gläser, 
Germany), and stored at − 20 °C. The antisense cRNA 
hybridization probe was 486 bp long, covering exons 1–4 
(forward primer: GTG GAG GGA AGG AGA AGG AC; reverse 
primer: TCC CGG ACT TTG ATG AAC TC) and using Basic 
Local Alignment Tool (BLAST, NCBI, NIH) optimized for 
both highly similar sequences (megablast) and more dissimi-
lar sequences (discontiguous megablast), indicate that our 
riboprobe would only bind to one transcript corresponding 
to DRR1. The intensity of the DRR1 mRNA expression has 
been shown to increase in virus-mediated DRR1 overexpres-
sion (Schmidt et al. 2011; Masana et al. 2014). Sections were 
fixed in 4% paraformaldehyde, acetylated in 0.25% acetic 
anhydride and dehydrated in increasing concentrations of 
ethanol. Each slide was exposed to 100 µl of hybridization 
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buffer containing 3–5 × 106cpm  [35S] labeled riboprobe, 
coverslipped and incubated overnight at 55 °C. The next 
day, sections were rinsed in 2x standard saline citrate (SSC), 
treated with RNAse A (20 mg/l) at 37 °C and washed in 
decreasing SSC concentration solutions at room tempera-
ture. Then, sections were washed in 0.1 × SSC for 1 h at 
65 °C and dehydrated through increasing concentrations of 
ethanol. Finally, slides were exposed to Kodak Biomax MR 
films (Eastman Kodak Co., Rochester, NY, USA), developed 
and the autoradiographs digitized. For increased resolution 
of the neuroanatomical expression pattern of DRR1 mRNA 
a silver grain staining was performed. Sections were dipped 
in Kodak NTB emulsion (Eastman Kodak Co., Rochester, 
NY), exposed for 3 days at 4 °C, and then developed in 
Kodak D19 solution. The developed slides were lightly 
counterstained with cresyl violet.
Immunofluorescence
Immunofluorescence stainings were performed as previously 
described (Schmidt et al. 2011; Masana et al. 2014). Ani-
mals were deeply anesthetized with ketamin/rompun and 
perfused intracardially with 4% paraformaldehyde; brains 
were removed, post-fixed overnight in 4% paraformaldehyde 
following overnight incubation in 20% sucrose solution at 
4 °C, frozen in isopentane at − 40 °C. All brain tissue was 
subsequently stored at − 20/− 80 °C until use. Free-float-
ing sections were cut at 30 µm using a cryostat microtome, 
thaw-mounted on Superfrost slides (Menzel Gläser, Ger-
many) and stored at − 20 °C until immunofluorescence 
staining was performed. Phosphate buffer 0.1 M (PB) was 
used for all washing steps, and all reagents were diluted in 
PB. Sections were washed in 0.3% Triton-X100, blocked for 
1 h in 5% normal donkey serum (Abcam) in 0.3% Triton-
X100, and incubated with the primary antibodies overnight 
at 4 °C. Sections were washed and incubated for 2 h with 
Alexa Fluor-conjugated secondary antibodies (1:500) at 
room temperature, and washed again. Then, rinsed in dis-
tilled water, mounted on superfrost plus slides, and covered 
with Vectashield mounting medium (Vector Laboratories, 
Burlingame, USA) containing DAPI. The rabbit polyclonal 
antibody against DRR1 was produced by Biogenes (Berlin, 
Germany) using recombinant DRR1 in rats and affinity-
purified (with the same antigen) (Schmidt et al. 2011) and 
it has been used for Western blotting and immunostaining 
before (Masana et al. 2014; Schmidt et al. 2011). While 
there is no DRR1-knock-out available, the specificity of the 
antibody had been assessed as follows: (1) In Western blot 
analyses, the antibody recognizes recombinant DRR1, as 
well as DRR1 in extracts from cells transfected to express 
DRR1 and from brain tissue expressing DRR1 (Schmidt 
et al. 2011). (2) The intensity of the DRR1 protein expres-
sion by immunofluorescence increases in virus-mediated 
overexpression (Schmidt et al. 2011; Masana et al. 2014). 
Also mouse anti-neuronal nuclei (NeuN) (1:500; Mil-
lipore); goat anti-synaptophysin (1:250; SantaCruz); goat 
anti-PSD-95 (1:500; Abcam) and the appropriate secondary 
antibodies linked to Alexa Fluor 488/555/647 (Invitrogen) 
were used.
Image acquisition and analysis
Silver grain stainings of in situ hybridization were examined 
using an Axioskop2 microscope and photomicrographs were 
taken with Axiovision software (Zeiss, Jena, Germany). 
Images of immunofluorescence stainings were obtained with 
a laser-scanning confocal microscope (IX81-FV1000, Olym-
pus, Tokyo, Japan) using Olympus FV10-ASW 2.0 software. 
All images were processed with the FIJI software (Schin-
delin et al. 2012). Representative images were adjusted 
for brightness and contrast. Overview figures were cre-
ated from 16 to 30 single images using the MosaicJ plugin 
(Thévenaz and Unser 2007). The different anatomical brain 
regions were identified with the mouse brain atlas (Paxinos 
and Franklin 2008). Signal intensities were rated into one 
of the following categories: − not detectable, + weak sig-
nal, ++ moderate signal and +++ strong signal, according 
to the grey-intensity levels in the autoradiograph and also 
the expression observed in the high-resolution photomicro-
graphs of  [35S]-labeled DRR1 mRNA. Densitometric quan-
tification of autoradiographs of  [35S]-labeled mRNA was 
done using the Fiji software and grey values were expressed 
as arbitrary units (a. u.). Four different brain slices/ animal 
were measured. Background signal was subtracted outside 
the tissue section.
Western blot
For total protein detection, hippocampi were dissected and 
frozen on dry ice, homogenized in 100 μl ice-cold lysis 
buffer (50 mM Tris/HCl, 250 mM sucrose, 1 mM EDTA, 
1:100 protease inhibitor cocktail P2714 (Sigma Aldrich), pH 
adjusted to 7.5), centrifuged 10 min at 8000 rpm, the super-
natant was centrifuged again 10 min at 7000 rpm, at 4 °C. 
Cytosol (F1), membranes (F2), nuclear (F3) and cytoskeletal 
(F4) fractions were separated using a commercially avail-
able kit  (ProteoExtract® Subcellular Proteome Extraction 
Kit, Calbiochem, 539790). Protein concentrations were 
determined using a detergent compatible protein assay kit 
(Bio-Rad, Hercules, CA, USA). Samples containing 40 µg of 
protein were resolved by 15% sodium dodecyl sulphate–pol-
yacrylamide gels, and transferred onto nitrocellulose mem-
branes (GE Healthcare).
A second subcellular separation was done according to 
the protocol described in Gardoni et al. (2006) and Trec-
cani et al. (2014). Each pool of tissue was homogenized 
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in 0.32 M ice-cold sucrose containing (in mM): 1 HEPES, 
1  MgCl2, 1 EDTA, 1  NaHCO3, and 0.1 PMSF, at pH 7.4, 
with a complete set of protease inhibitors (Complete; Roche 
Diagnostics, Basel, Switzerland) and phosphatases inhibitors 
(Sigma, St. Louis, MO, USA). The hippocampi homogenate 
was centrifuged 10 min at 1000g. The obtained supernatant 
(S1) was centrifuged 15 min at 3000g. The cytosol fraction 
was obtained (S2 fraction) and the pellet (P2 fraction, crude 
membrane fraction) was resuspended in 1 mM HEPES plus 
CompleteTM in a glass–glass potter and centrifuged 1 h at 
100,000g. The pellet (P3 fraction) was resuspended in buffer 
containing 75 mM KCl and 1% Triton X-100 and centri-
fuged 1 h at 100,000g. The supernatant (S4 fraction, Triton 
X-100-soluble fraction (TSF)) was obtained and the final 
pellet (P4 fraction, TIF) was homogenized in a glass–glass 
potter in 20 mM HEPES, an equal volume of glycerol was 
added and stored at − 80 °C until processing.
Membranes were labeled with rabbit anti-DRR1 (1:2000, 
BioGenes), goat anti-actin (1:2000, Santa Cruz Biotechnol-
ogy), rat anti-tubulin (1:5000, Abcam) antibodies overnight 
at 4 °C. Following incubation with the corresponding horse-
radish peroxidase-conjugated (1:2000, DAKO) secondary 
antibodies for 3 h. Bands were visualized using an enhanced 
chemiluminescence system (Millipore), detected using the 
Chemidoc system (BioRad) and quantified by densitometry 
(Image Lab Software, Bio-Rad). Duplicates of each sample 
were loaded and measured independently.
Statistical analysis
The commercially available program GraphPad Prism 4 
was used for statistical analysis. Simple group compari-
sons were performed using the two-tailed unpaired t test. If 
more than two groups were compared, an ANOVA was per-
formed followed by Bonferroni post hoc analysis. The level 
of significance was set at p < 0.05. All data are presented as 
mean + SEM.
Results
DRR1 mRNA expression in the adult mouse brain
DRR1 mRNA is widely expressed in the whole adult mouse 
brain (Fig. 1; S1; S2; Table 1) with a distinct neuroanatomi-
cal expression intensity profile. From anterior to posterior 
relative to bregma, the strongest DRR1 mRNA expression 
was detected in the posterior part of the lateral septum; the 
subfornical organ; the cell bodies of the pyramidal CA3 
region of the hippocampus, specifically the CA3a and ini-
tial part of CA3b subfield; and cells ensheathing the stalk 
of the habenular commissure and the Purkinje cell layer of 
the cerebellum.
Moderate DRR1 gene expression was visible, but not uni-
formly distributed, throughout the cortex. Especially high 
expression was detected in the primary somatosensory cor-
tex and the retrosplenial cortex (both granular and agranular 
part). Interestingly, the cortical layer V (the inner pyramidal 
layer) displayed lower DRR1 mRNA expression compared 
to the other cortical layers. Moderate DRR1 expression 
was also found in the lateral part of the caudate putamen, 
the amygdala, the mammillary nuclei and several thalamic 
(ventromedial hypothalamic nucleus and the parafascicular 
thalamic nucleus) and hypothalamic nuclei.
Only very weak DRR1 mRNA expression was visible 
in the mesencephalon and the rhombencephalic medulla 
oblongata and pons.
Whereas weak to strong DRR1 expression was found in 
neuronal tissue throughout the brain, DRR1 mRNA expres-
sion was less observed in white matter structures like the 
anterior commissure, the corpus callosum, the cerebral 
peduncle and the optic tract. We can observe a punctate 
pattern in the high-resolution silver grain-stained DRR1 
mRNA images; however, intensity of the signal provided by 
the autoradiograph is almost undetectable. Interestingly, the 
expression of DRR1 mRNA was also detected in the choroid 
plexus and in ependymal cells of the brain ventricles, similar 
to Fam107B (Masana et al. 2015).
Neuroanatomical distribution of DRR1 protein
The neuroanatomical distribution of DRR1 protein was 
assessed by immunofluorescence. DRR1 protein could 
be found throughout all the adult mouse brain, with high 
expression in specific regions (Table 1; Figs. 2, 3).
The DRR1 protein abundance in the septum nicely fol-
lowed the pattern of mRNA expression with high DRR1 pro-
tein levels in the lateral septum. Moreover, also the caudate 
putamen, lateral globus pallidus, ventral pallidum as well 
as the nearby bed nucleus of the anterior commissure and 
the bed nucleus of the stria terminalis were DRR1 positive 
(Fig. 2a).
Within the cortex, DRR1 was found throughout all 
regions and layers of the cortex (Fig. 2b). Immunofluo-
rescence outlines neuronal cell bodies of cortical neurons 
(arrows in Fig. 2b1) but was also located to the surrounding 
neuropil. Particularly high density of DRR1 signal could be 
observed in layer IV of the barrel field, where it appears in 
barrel like structures (Fig. 2b2). Whereas the mRNA sig-
nal was clearly reduced within layer V of the cortex, DRR1 
protein is not. Comparable levels of DRR1 protein were also 
found in the amygdala (Fig. 2b4).
Moreover, strong DRR1 protein expression was present 
in the hippocampus and the adjacent habenular commissure 
(Fig. 2c1, c2). High protein levels could be found promi-
nently in CA3 cell bodies but also in the dentate gyrus and 
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Fig. 1  DRR1 mRNA showed distinct expression throughout the 
adult mouse brain. a Representative autoradiograms of  [35S]-labeled 
DRR1 coronal brain sections from the same mouse at different ante-
rioposterior (AP) location in relation to bregma. b–e High-resolution 
photomicrographs showing the expression pattern of DRR1 mRNA 
revealed by silver grain staining under dark-field illumination. Pic-
tures show mosaics of several photomicrographs at b AP: − 0.3; 
c AP: 1.8; d 2.5 and e 5.5 mm from bregma (Paxinos and Franklin 
2008). aca Anterior commissure, cc corpus callosum, CA3 cornu 
ammonis 3, fr fasciculus retroflexus, hbc habenular commissure, ic 
inferior colliculus, LS lateral septum, LV lateral ventricle, MM mam-
millary nucleus, Mo molecular layer of the cerebellum, Nu nuclear 
layer of the cerebellum, PF parafascicular thalamic nucleus, Pn pon-
tine nuclei, P Purkinje cell layer of the cerebellum, RS retrosplenial 
cortex, 3V third ventricle
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the molecular layers. Additionally, cells covering the stalk 
of the habenular commissure were positive for both DRR1 
mRNA and protein (Table 1; Fig. 2c2).
The cerebellum was one of the brain regions with the 
highest DRR1 protein level. DRR1 protein signal was strong 
in the Purkinje layer (cell bodies) and molecular layer of the 
cerebellum (Fig. 2c3). Because very strong mRNA expres-
sion of DRR1 was only visible in the Purkinje cell layer, it is 
likely that most of the DRR1 protein in the molecular layer 
belongs to Purkinje cell dendrites.
The distribution of DRR1 protein in the thalamus and 
hypothalamus is summarized in Table 1. Several nuclei 
showed moderate DRR1 protein levels as indicated. High 
DRR1 abundance could be observed in the mammillary 
nuclei while the paraventricular nucleus of the hypothalamus 
showed only basal levels of DRR1.
Table 1  DRR1 expression in the mouse brain
Brain structure mRNA levels Protein levels
Cortex
 Layer I ++ ++
 Layer II ++ ++
 Layer III ++ ++
 Layer IV ++ +++
 Layer V −/+ ++
 Layer VI ++ ++
Hippocampal region
 CA3 +++ ++
 CA2 + +
 CA1 + +
 Granular layer of the dentate gyrus + +
 Polymorphic layer of the dentate 
gyrus
+ +
 Molecular layer of the dentate gyrus + ++
 Stratum lacunosum-moleculare + ++
 Stratum radiatum − +
Septal region
 Lateral septal nucleus +++ ++
 Medial septal nucleus ++ ++
 Septohippocampal nucleus ++ ++
 Septofimbrial nucleus + +
 Bed nucleus of anterior commissure n/a ++
 Median preoptic nucleus n/a ++
Basal ganglia and related areas
 Caudate putamen ++ ++
 Globus pallidus + ++
 Bed nucleus of the stria terminalis + ++
 Substantia nigra − +
 Subthalamic nucleus + ++
Thalamus
 Habenular nuclei + ++
 Habenular commissure +++ +++
 Reuniens thalamic nucleus + ++
 Parafascicular thalamic nucleus ++ ++
 Zona incerta ++ ++
 Ventral pallidum + ++
 Posterior thalamic nuclear group + ++
 Dorsal/ventral lateral geniculate 
nucleus
+ ++
 Bed nucleus of the stria terminalis + ++
Hypothalamus
 Paraventricular hypothalamic nucleus + +
 Peri-PVN region + +
 Ventromedial hypothalamic nucleus ++ +
 Lateral mammillary nucleus +++ +++
 Medial mammillary nucleus +++ +++
 Supraoptic nucleus n/a ++
 Arcuate hypothalamic nucleus ++ ++
 Suprachiasmatic nucleus ++ ++
Relative expression levels of DRR1 mRNA and protein in adult 
mouse brain is expressed in the following four categories: − not 
detectable, + weak signal, ++ moderate signal and +++ strong sig-
nal, mRNA expression levels was classified into four categories 
according to intensity levels of mRNA expression in autoradiographs 
and photomicrographs (Figs.  1, S1, S2). Only regions that could be 
clearly assigned with regard to DRR1 mRNA or protein expression 
were included
Table 1  (continued)
Brain structure mRNA levels Protein levels
Amygdaloid complex
 Basolateral amygdaloid nucleus ++ ++
 Basomedial amygdaloid nucleus ++ ++
 Central amygdaloid nucleus + ++
Circumventricular organs
 Subfornical organ +++ +++
 Subcommissural organ − ++
 Organum vasculosum lamina termi-
nalis
n/a ++
 Median eminence − +
 Pituitary n/a n/a
 Area postrema n/a ++
Cerebellum
 Purkinje cell layer +++ +++
 Molecular layer ++ +++
 Granular layer + +
White matter structures
 Corpus callosum + +
 Anterior commissure − +
 Fornix − +
 Optic tract − ++
 Ventral hippocampal commissure − +
 Cerebral peduncle − +
Non-neuronal tissue
 Choroid plexus ++ ++
 Ventricular Ependymal cells ++ ++
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Interestingly, most of the circumventricular organs 
(CVOs) were strongly labeled by DRR1 immunofluores-
cence (Fig. 3). High levels of DRR1 could be observed in 
the vascular organ of the lamina terminalis, the area pos-
trema, the subfornical organ and the subcommissural organ, 
but not the median eminence. A broader definition of CVOs 
includes also the choroid plexus, which showed prominent 
DRR1 mRNA and protein (Table 1; Fig. 3g). Also nuclei 
known to be highly interconnected with the CVOs, the 
supraoptic nucleus (data not shown) and the median preop-
tic nucleus (Fig. 2a3), do express DRR1.
DRR1 was prominently but not exclusively located to 
neurons, as it is found in virtually all neurons but also in 
non-neuronal tissue like in the cells of the choroid plexus 
and the ependyma (Fig. 3g, h).
Cellular localization of DRR1 protein
DRR1 protein appeared in a punctate pattern independent of 
the neuroanatomical region and the intracellular localization 
(Figs. 2, 3). DRR1 was found in the neuropil as well as in the 
neuronal somata including the nuclei, where it shows denser 
signal. DRR1 was also located to cellular specializations as 
it was found in cilia of ependymal cells (Fig. 3h).
Furthermore DRR1 might be located to both presynaptic 
and postsynaptic structures (Figure S1). DRR1 co-localize 
with some of the synapsin and PSD-95 labeled structures. 
Thus, DRR1 appears to be a putative but not integral part of 
synaptic structures.
Glucocorticoids increase DRR1 mRNA in grey 
and white matter of the adult mouse brain
The GR agonist dexamethasone (10 mg/Kg s.c.) increased 
DRR1 mRNA throughout the whole adult mouse brain, as 
shown in the representative autoradiographs of  [35S]-labeled 
DRR1 mRNA (Fig. 4a) and densitometric analysis (Fig. 4b).
Under basal conditions, DRR1 mRNA showed maximum 
expression (in arbitrary units, a.u.) in the hippocampal CA3 
region (79 ± 6), followed by the lateral septum (48 ± 3) and 
the primary somatosensorial cortex-Barrel field (49 ± 6), 
motor cortex (40 ± 5), striatum (25 ± 2) and with low (almost 
undetectable) expression in white matter fiber tracts such 
as the anterior commissure (12 ± 3) and corpus callosum 
(12 ± 3).
After glucocorticoid receptor activation, DRR1 
mRNA levels increased significantly (Student’s t test) in 
all DRR1-rich regions but also in white matter regions. 
In detail, dexamethasone treatment increased mRNA 
expression in grey matter approximately 136% in the hip-
pocampal CA3 region, 186% in the lateral septum, 145% 
in the primary somatosensorial cortex-Barrel field, 152% 
in the motor cortex and 195% in the striatum; while in 
fiber tracts increased 436% in the anterior commissure 
and 401% in the corpus callosum, reaching similar levels 
to neighboring areas such as striatum and cortex. Within 
the hippocampus, we could observe qualitatively increases 
in all CA3, DG and CA1 pyramidal neurons, and also in 
the str. Lac/mol and Str. Moleculare, and hilus, but this 
increase was less evident in the str. Radiatum. Within the 
cortex, DRR1 mRNA expression increased in all areas, 
with the somatosensory barrel field area showing the max-
imum expression. Moreover, the differential expression 
intensity pattern through the different cortical layers was 
maintained after dexamethasone treatment, with higher 
expression in layer IV and low expression in layer V.
Interestingly, DRR1 was also strongly increased in the 
epithelium surrounding hippocampus, around ventricles 
and in the choroid plexus.
Glucocorticoids increase DRR1 in the membrane 
fraction
DRR1 protein levels were increased by dexamethasone 
(10 mg/kg s.c.) treatment compared to vehicle in the mouse 
hippocampus, and at greater extent in membrane-rich frac-
tions. Dexamethasone increased total protein expression of 
DRR1 in the hippocampus (Fig. 5a) (p < 0.0001 vs actin; 
p < 0.05 vs tubulin) but not in the cerebellum (data not 
shown) when compared to vehicle-treated mice (n = 6 
mice/group).
Subcellular fractioning of hippocampal dissected tis-
sue showed that DRR1 is expressed ubiquitously in the 
cell and dexamethasone increased DRR1 protein expres-
sion significantly in the membrane (F2) (p < 0.05), but 
not cytosol (F1), nuclei (F3) or cytoskeleton fractions 
(F4) (Fig. 5b) compared to vehicle-treated mice (n = 6 
mice/group). Second subcellular fractioning showed that 
dexamethasone increased DRR1 in the crude membrane 
fraction (P2) (p < 0.05), cytosol (S2) (p < 0.05), postsyn-
aptic membrane fraction (Triton-insoluble fraction, TIF) 
(p < 0.05) and Triton-soluble fraction (TSF) (p < 0.05) 
[when normalized to tubulin; all of them when normal-
ized to actin (not shown)] (Fig. 5c). In all experiments 
corticosterone levels were measured and were significantly 
reduced in dexamethasone-treated mice compared to vehi-
cle: 46.8 ± 10.6 and 0.7 ± 0.3 ng/ml for the total protein/
subcellular fraction experiment in Veh and DEX-treated 
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mice, respectively (n = 11–12 mice/group); and 66.6 ± 10.6 
and 1.2 ± 1.3 ng/ml for the alternative subfraction proce-
dure in Veh and DEX-treated mice, respectively (n = 16 
mice/group). Corticosterone levels were measured and 
were significantly reduced in dexamethasone-treated mice 
compared to vehicle (Figure S4).
Discussion
The characterization of molecular targets able to modu-
late stress resilience is fundamental in the search for treat-
ments of stress-related disorders. The stress-inducible 
protein DRR1 was recently proposed as a novel molecular 
player able to modulate and attenuate the aversive conse-
quences of stress (Masana et al. 2014; van der Kooij et al. 
2016). In the present study, we provide a comprehensive 
description of the neuroanatomical expression of DRR1 in 
the adult mouse brain and its regulation by glucocorticoids. 
Our results indicate that DRR1 is ubiquitously expressed in 
the cell and specifically expressed in distinct brain regions 
under basal conditions. In addition, glucocorticoids increase 
DRR1 expression in membrane-rich structures in the cell 
and throughout the whole brain, showing greater increase in 
white matter tracts, where it is not detected under baseline 
conditions.
DRR1 is expressed in radial glia during development 
(Pollen et al. 2015), and later in neurons, astrocytes and 
oligodendrocytes (Cahoy et al. 2008; Masana et al. 2014; 
Hochgerner et al. 2018), with particularly strong upregula-
tion and most highly expressed in late developing astrocytes 
(Cahoy et al. 2008). Here, we further extend the characteri-
zation of expression of DRR1 to non-neuronal tissue such 
as the choroid plexus and ependyma. These data indicate 
that glucocorticoids could modulate the physiology of both 
neuronal and non-neuronal brain cells through the modu-
lation of DRR1 expression, probably by modulating actin 
reorganization and dynamics using similar mechanisms (Le 
et al. 2010; Schmidt et al. 2011).
In addition, DRR1 is ubiquitously expressed throughout 
the cell. This is shown by the expression of DRR1 in all 
the different subcellular fractions and the pattern of expres-
sion detected by immunohistochemistry, where the punctate 
DRR1 pattern can be found inside and around the nucleus 
and also the neuropil, as previously described for the lat-
eral septum (Masana et al. 2014). This expression pattern 
is confirmed in other brain regions, and is especially clear 
in the cerebellum, where DRR1 is strongly expressed in the 
soma and dendrites of Purkinje cells. The presence of DRR1 
protein in regions where mRNA expression is lacking is sug-
gestive of DRR1 expression in distant axons and/or dendrites 
and is consistent with the expression of DRR1 in axonal 
projections found in mouse development (Asano et al. 2010). 
Another example would be layer V of the cortex, where 
nearly no mRNA signal was observed under both basal and 
dexamethasone stimulation, but showed protein expression. 
These data, together with the expression of DRR1 protein in 
membrane-rich structures and in the synapse, suggests that 
DRR1 is expressed in dendrites and/or axons, In addition, 
DRR1 is expressed in TIF and TSF fractions and partially 
co-localizes with synapsin and PSD95, indicating that DRR1 
is a putative but not integral part of synaptic structures.
In the brain, DRR1 is expressed in CVOs, suggesting its 
potential role in the regulation of brain homeostasis (Denton 
et al. 1996). Interestingly, CVOs lack the blood–brain barrier 
and thus circulating blood can penetrate directly to the brain 
through the fenestrated vessels (Sisó et al. 2010). Moreover, 
the presence of DRR1 in cilia from epithelial cells further 
suggests that DRR1 containing structures could be relevant 
for sensory information from the cerebrospinal fluid (Singla 
and Reiter 2006) through changes in cytoskeletal structure 
and/or dynamics. Interestingly, cilia and dendrites show 
structural similarities (Nechipurenko et al. 2013), suggesting 
similar functions in neurons. In this line, DRR1 is expressed 
strongly in layer IV of the somatosensory barrel field, whose 
barrel neurons are the major target for somatosensory inputs 
Fig. 2  DRR1 protein is expressed in specific regions through-
out the entire adult mouse brain. Representative confocal images 
show immunofluorescence of DRR1 (red) and NeuN (green) or 
DAPI (blue) from a the striatal and septal region (0.2 to − 0.1  mm 
from bregma), b cerebral cortex and amygdala region (− 0.7  mm 
from bregma) and c hippocampal and cerebellar regions (− 1.8 and 
− 5.5  mm from bregma, respectively). Specifically, expression of 
DRR1 was found in the lateral septum (a1, a3), striatum (a2), median 
preoptic nucleus (a3), bed nucleus of the anterior commissure and 
subfornical organ (a4), primary motor cortex (b1), barrel field (b2), 
secondary somatosensory cortex (b3), amygdala (b4), hippocampus 
(c1), habenular commissure (c2) and Purkinje cell layer and molec-
ular layer of the cerebellum (c3). aca Anterior commissure anterior 
part, BAC bed nucleus of the anterior commissure, BLA basolateral 
amygdaloid nucleus, BST bed nucleus of the stria terminalis, CA1 
cornu ammonis 1, CA3 cornu ammonis 3, cc corpus callosum, Ce 
central amygdaloid nucleus, CPu caudate putamen, Cx cortex, D3V 
dorsal 3rd ventricle, DG dentate gyrus, f fornix, gl granular layer 
of the cerebellum, GrDG granular layer of the DG, LMol lacuno-
sum moleculare layer, hbc habenular commissure, LS lateral sep-
tal nucleus, MHb medial habenular nucleus, LHb lateral habenular 
nucleus, MnPO median preoptic nucleus, ml molecular layer of the 
cerebellum, Mol molecular layer, Or oriens layer, PoDG polymorph 
layer of the dentate gyrus, pl Purkinje cell layer of the cerebellum, 
Py pyramidal cell layer, Rad stratum radiatum, SFi septofimbrial 
nucleus, SFO subfornical organ
◂
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from the thalamus (Schubert et al. 2003). The lateral septum 
has also a key role in integrating information from affective 
brain regions, especially from hippocampus and hypothala-
mus among others (Sheehan et al. 2004). Also, the hypo-
thalamus, where DRR1 expression is strongly induced by 
dexamethasone in hypothalamic neural-progenitor/stem cells 
derived from mouse embryos (Frahm et al. 2016, 2017), 
integrates inputs from many central and peripheral sources 
to maintain homeostasis of different organ systems and 
whole body metabolism (Denton et al. 1996).
Glucocorticoid receptor activation is able to increase the 
mRNA expression in almost all brain regions, except for 
few regions such as layer V from cortex or stratum radia-
tum in the hippocampus, where DRR1 mRNA expression is 
also not detected under baseline conditions. However, it is 
Fig. 3  DRR1 protein is expressed in most of the circumventricular 
organs. a Schematic overview of the location of the different cir-
cumventricular organs in the mouse brain. Representative confocal 
images show immunofluorescence of DRR1 (red) and DAPI (blue) 
from b the subfornical organ (0.8  mm posterior to bregma), c the 
subcommissural organ (2.5 mm posterior to bregma), d the vascular 
organ of the lamina terminalis (0.50  mm anterior to bregma), f the 
area postrema, (1.7  mm posterior to bregma) e but not the median 
eminence. DRR1 protein can also be found in non-neuronal cells 
of g the choroid plexus and the ventricle ependyma. h In some rare 
cases, DRR1 was found in cilia of ependymal cells. 3V 3rd ventricle, 
AP area postrema, chp choroid plexus, hbc habenular commissure, 
ME median eminence, OVLT vascular organ of the lamina terminalis, 
SCO subcommissural organ, SFO subfornical organ
4049Brain Structure and Function (2018) 223:4039–4052 
1 3
particularly intriguing that DRR1 expression is increased by 
glucocorticoids especially in white matter tracts, i.e., corpus 
callosum, anterior commissure. One possible explanation is 
that DRR1 mRNA could be strongly induced in oligoden-
drocytes, where DRR1 is lowly expressed under baseline 
conditions (Cahoy et al. 2008), and/or a consequence of 
an increase in corticosteroid-induced oligodendrogenesis 
(Chetty et al. 2014). In this line, glucocorticoid receptor 
expression is especially strong in white matter tracts in the 
adult mouse (Quinn et al. 2016). Another possibility is that 
DRR1 mRNA is transported to the terminal, as for example 
the actin-regulating protein Arc (Huang et al. 2007). Accord-
ingly, stress-induced DRR1 protein expression is increased 
in membrane structures, but not in the nucleus. However, 
changes in the ratio of G-/F-actin in the cytosol could 
modulate serum response factor responsiveness (Olson and 
Nordheim 2010; Knöll 2011). Thus, stress might indirectly 
modulate gene transcription of immediate early genes and of 
actin cytoskeleton genes through DRR1 changes.
In conclusion, we provide further evidence that the 
actin-interacting protein DRR1 expression is induced by 
glucocorticoids, especially in membrane-rich structures 
and white matter tracts. As glucocorticoids-mediated 
mechanisms are prominent in the late phase response to 
stress (de Kloet et al. 2005), DRR1 induction could be 
involved in homeostasis restoration after stress and the 
storage of information in preparation for future use. How-
ever, stress disorders are more prevalent in women than 
in men; thus, further studies comparing male and female 
Fig. 4  The glucocorticoid-agonist dexamethasone increased DRR1 
mRNA expression in grey matter and fiber tracts. a Representa-
tive in  situ hybridization autoradiographs of  [35S]-labeled DRR1 
mRNA of mice injected with dexamethasone (DEX) (10 mg/Kg s.c.) 
or vehicle (Veh). b Densitometric quantification of dexamethasone-
induced DRR1 mRNA expression compared to vehicle. Bars show 
mean ± SEM of grey values in arbitrary units (a.u.). **p < 0.001 and 
***p < 0.0001 vs vehicle (t test). CA3 cornu ammonis 3, cc corpus 
callosum, CPu caudate putamen, LS lateral septal nucleus, S1B pri-
mary somatosensory cortex-Barrel field
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Fig. 5  Dexamethasone (10 mg/Kg s.c.) mostly increases DRR1 pro-
tein expression close to the membrane. DRR1 protein levels were 
measured in the mouse hippocampus by Western Blot. a Total DRR1 
protein levels; b DRR1 protein levels in the cytosol (F1), membranes 
(F2), nuclear (F3) and cytoskeletal (F4) subcellular fractions; and c 
DRR1 protein levels in nuclei-associated membranes (P1), crude 
membrane fraction (P2), cytosol (S2), Triton-insoluble fraction (TIF) 
and Triton-soluble fraction (TSF). Actin and tubulin were used as 
loading control. Bars show mean ± SEM ratios of DRR1/tubulin and 
DRR1/actin grey levels. *p < 0.05, **p < 0.001 and ***p < 0.0001 vs 
vehicle (t test)
4051Brain Structure and Function (2018) 223:4039–4052 
1 3
DRR1 expression and regulation by glucocorticoids should 
be addressed for translational relevance. Finally, these data 
might be a useful to understand DRR1-dependent physi-
ology and to extend the knowledge on stress resilience 
mechanisms that could help to develop future therapeutic 
interventions.
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